Posted in | News | Aluminum / Aluminium

Phase II Mozal Aluminium Smelter Opened

Oct 13 2003

Related Stories

The second phase of the Mozal aluminium smelter in Mozambique was opened on October 8th. The Mozal project is owned by BHP Billiton (47%), Mitsubishi Corp (25%), the Industrial Development Corp of South Africa (24%) and the Government of Mozambique (4%).

Following on from the success of phase I which was completed 6 months ahead of schedule and US$100 million under budget, phase II was completed in 26 months, 7 months ahead of schedule and a staggering US$195 million under budget. The phase II expansion involved the construction of another 288 pots, adding 253,000 tonnes per year capacity, which doubles the plants’ capacity.

The plant is currently exceeding its design capacity of 506,000 tonnes of aluminium per year. Furthermore, it is achieving this at one of the industries lowest production costs.

For more information on aluminium, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback